Venous Stents Market Size to Reach USD 2.62 Billion by 2033 | Growing at 8.5% CAGR Driven by Rising Prevalence of Venous Disorders

The Venous Stents Market reached US$ 1.24 billion in 2024 and is projected to reach US$ 2.62 billion by 2033, growing at a CAGR of 8.5% during the forecast period 2025 to 2033.

Venous stents are expandable metal mesh tubes designed to apply outward pressure against narrowed or obstructed veins, functioning as scaffolds to maintain proper blood flow. These devices are typically placed in large central veins located in the abdomen, chest, and lower extremities. Venous stents play a critical role in the treatment of conditions such as chronic deep vein thrombosis, hemodialysis related arteriovenous fistulae complications, May Thurner syndrome, Nutcracker syndrome, and post thrombotic syndrome.

Deep vein thrombosis occurs when a blood clot forms in a deep vein, most commonly in the legs, potentially leading to serious complications such as pulmonary embolism if untreated. The rising global incidence of venous disorders, increasing prevalence of sedentary lifestyles, growing aging population, and advancements in minimally invasive endovascular procedures are major factors driving market growth. Technological improvements in stent design, including enhanced flexibility, radial strength, and long term patency rates, are further supporting adoption across healthcare facilities worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/venous-stents-market?sai-v

The Venous Stents Market refers to the global industry focused on the development and commercialization of stent devices designed to treat venous obstructions and improve blood flow in conditions such as deep vein thrombosis and chronic venous insufficiency.

Key Developments

✅ February 2026: In North America and Europe, Boston Scientific expanded its venous stents portfolio by launching next-generation self-expanding and high-radial-force venous stent systems designed to improve long-term patency and reduce post-implant complications, and announced plans to extend clinical training programs and evidence-generation studies throughout 2026.

✅ January 2026: In global vascular access markets, BD (Becton Dickinson) introduced enhanced venous stent delivery systems with improved navigability and precision deployment features, with future initiatives focused on broadening surgeon education and post-market surveillance.

✅ December 2025: In Europe and Asia Pacific, Medtronic strengthened its venous stent portfolio with next-generation nitinol and polymer-coated devices aimed at peripheral venous and iliac vein applications, and outlined plans for expanded investigator-initiated registries and real-world evidence collection.

✅ November 2025: In North America, Cook Medical launched upgraded venous stent platforms with enhanced sizing options and delivery catheters, and announced plans to increase distribution partnerships in emerging markets.

✅ October 2025: Across global endovascular markets, AngioDynamics expanded its venous stent offerings with integrated imaging guidance accessories and optimized delivery systems, with future development focused on hybrid procedure compatibility.

✅ September 2025: In Europe and Latin America, Terumo Corporation progressed its portfolio of venous stent technologies with improved radial strength and trackability, and outlined planned collaborations with vascular specialists to support adoption and training.

Key Players
Medtronic plc | Boston Scientific Corporation | Cook Medical LLC | Terumo Corporation | Becton Dickinson and Company | Abbott Laboratories | Cordis Corporation | Vesper Medical Inc. | Bentley InnoMed GmbH | OptiMed Medizinische Instrumente GmbH | Others

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=venous-stents-market?sai-v
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Market Drivers

Increasing Prevalence of Venous Diseases: Rising incidence of chronic venous insufficiency, deep vein thrombosis (DVT), and post-thrombotic syndrome due to aging populations, sedentary lifestyles, and comorbid conditions is driving demand for venous stent therapies.

Growing Adoption of Minimally Invasive Endovascular Treatments: Clinicians are favoring less invasive procedures such as percutaneous venous stenting over traditional surgery, due to reduced hospital stays, faster recovery, and improved patient outcomes.

Advancements in Stent Design and Materials: Development of novel stent architectures, drug-eluting coatings, flexible nitinol alloys, and enhanced deliverability systems is improving patency rates and lowering restenosis risk.

Expansion of Interventional Vascular Procedures: Increased procedural volumes in hospitals and outpatient surgical centers, supported by expanding interventional radiology and vascular surgery capabilities, are contributing to broader stent adoption.

Improved Diagnostic and Imaging Techniques: Enhanced intravascular imaging (IVUS, OCT), duplex ultrasound, and CT venography enable better lesion assessment, procedural planning, and stent placement accuracy.

Industry Developments

Launch of Next-Generation Venous Stent Systems: Manufacturers are introducing stents with improved radial force, optimized deployment delivery systems, lesion-specific designs, and advanced surface coatings to support long-term vessel patency.

Growth of Drug-Eluting and Bioactive Stent Technologies: Development of drug-coated and bioactive stents that reduce neointimal proliferation and restensosis risk is advancing clinical performance and expanding therapeutic use.

Strategic Collaborations Between Device Makers and Clinical Institutions: Partnerships focused on clinical research, real-world evidence generation, and shared training programs are accelerating adoption of venous stent procedures.

Integration of Advanced Imaging and Navigation Tools: Combining stent systems with IVUS, 3D imaging, and procedural navigation platforms enhances placement accuracy and procedural success.

Expansion of Disposable Accessory and Delivery Platforms: Expansion of compatible delivery catheters, sheaths, and support tooling improves procedural workflow and reduces complications in endovascular settings.

Regional Insights

North America - Holds around 40 percent share: Well-established interventional vascular infrastructure, high prevalence of venous disease, broad clinician adoption of advanced stent technologies, and favorable reimbursement frameworks support leading regional demand.

Europe - Holds around 27 percent share: Growing awareness of chronic venous conditions, strong vascular care protocols, and investment in minimally invasive therapies sustain steady market growth.

Asia Pacific - Holds around 25 percent share: Expanding healthcare infrastructure in China, India, Japan, and Southeast Asia, rising venous disease burden, and increasing procedural adoption drive rapid regional expansion.

Latin America - Holds around 6 percent share: Improving vascular care services, expanding access to interventional procedures, and growing clinician expertise contribute to emerging growth opportunities.

Middle East & Africa - Holds around 2 percent share: Development of specialty care centers, rising focus on non-communicable diseases, and initial adoption of advanced endovascular therapies support early stage market development.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/venous-stents-market?sai-v

Key Segments

By Product Type
Self expanding venous stents represent the dominant segment, driven by their flexibility, adaptability to vessel anatomy, and suitability for treating iliac and femoral vein obstructions. Balloon expandable venous stents hold a significant share, offering precise placement and controlled expansion in specific anatomical locations. Other product types include dedicated deep venous stents and hybrid designs developed to address complex venous lesions and chronic venous insufficiency.

By Material
Nitinol accounts for the largest share due to its shape memory properties, high flexibility, and resistance to corrosion, making it ideal for long term implantation in dynamic venous environments. Stainless steel is used in select applications where high radial strength and structural stability are required. Other materials include cobalt chromium and emerging alloy compositions designed to enhance durability, biocompatibility, and long term patency.

By Application
Deep vein thrombosis management represents a major application area, supported by increasing incidence and the need to restore venous blood flow. Chronic venous insufficiency accounts for a substantial share, driven by rising cases of venous obstruction and post thrombotic syndrome. Iliac vein compression syndrome and other complex venous disorders are expanding segments as awareness and diagnostic capabilities improve.

By End User
Hospitals dominate the segment due to advanced interventional radiology and vascular surgery facilities, along with high procedural volumes. Specialty clinics, particularly vascular and endovascular centers, are witnessing steady growth owing to minimally invasive treatment adoption. Other end users include ambulatory surgical centers and cardiovascular institutes that provide focused venous disease management services.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.